Although concern regarding the increased risk for new-onset diabetes mellitus (NODM) after
statin treatment has been raised, there has been a lack of evidence in real-world clinical …

Statin therapy is beneficial in reducing cardiovascular events and mortalities in patients with
atherosclerotic cardiovascular diseases. Yet, there have been concerns of increased risk of …

Aim We investigated the association between statin use and new-onset diabetes (NODM) in
Korean adults with hypercholesterolemia. Methods This study performed based on data from …

Background Several studies suggest that statin may increase the risk of new-onset diabetes
mellitus (NODM). This study aimed to evaluate the association between the duration and …

Background and aims Meta-analyses of randomized control trials investigating the
association between incident diabetes and statin use showed an increased risk of new …

Background Statins reduce cardiovascular risks but increase the risk of new-onset diabetes
(NOD). The aim of this study is to determine what effect, if any, statins have on the risk of …

BACKGROUND: Statins have been linked to new-onset diabetes (NOD); however, the effect
of statins on the development of NOD in patients with hypertension and dyslipidemia has not …

Background We evaluated the effect of statin use on new-onset type 2 diabetes among
individuals without atherosclerotic cardiovascular disease (ASCVD) using nationally …

Background Statins have been known to increase the risk of incident type 2 diabetes
mellitus (DM); however, other factors, especially hypertension, are also associated with DM …

Statins constitute the mainstay treatment for atherosclerotic cardiovascular disease, which is
associated with the risk of new-onset diabetes mellitus (NODM). However, the effects of …